Shire, AbbVie unveil $54 billion merger
Takeda and Shire finally agree takeover terms after months of negotiations – The New Economy
Massive Takeda Pharma buyout of Shire a high-risk move with uncertain rewards - The Mainichi
After profits dip Takeda may find solace in Shire merger, says GlobalData - European Pharmaceutical Manufacturer
Takeda breaks into top 20 largest pharmas with Shire merger | Pharmaphorum
Shire and Takeda come to terms with a $64B deal, the biggest pharma M&A in years | Fierce Pharma
Takeda Pharmaceutical and Shire receive shareholders' approval for Takeda- Shire deal | AlphaStreet
Takeda-Shire deal: the strategy behind Japan's largest foreign acquisition - Pharmaceutical Technology
Shire rejects £42.4bn Takeda offer as Allergan rules itself out | Financial Times
Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger
Takeda Acquisition Of Shire Officially Closes, CEO Christophe Weber Shares His Plans For The Future
Shire and Takeda to announce preliminary deal after breakthrough in merger talks: Reuters, citing sources
Japan drug giant Takeda tumbles as Shire recommends $64 bn offer
Takeda to sell nearly new Shire plant with 200 employees | Fierce Pharma
Takeda completes Shire acquisition - PharmaTimes
Takeda Pharmaceutical Agrees $62.4 Billion Takeover of Shire - TheStreet
Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum | Business Wire
News Release
Takeda Acquisition Of Shire May Bode Well For R&D Staff
Shire agrees $32bn takeover of Baxalta | Financial Times
Pharma giant Takeda enters into $7.5bn loan agreement to fund Shire takeover
Takeda takes biggest gamble of 2018 with Shire merger -
